{"id":88,"date":"2019-09-22T17:49:44","date_gmt":"2019-09-22T21:49:44","guid":{"rendered":"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/3-3-administration-considerations\/"},"modified":"2023-07-04T13:40:48","modified_gmt":"2023-07-04T17:40:48","slug":"3-3-administration-considerations","status":"publish","type":"chapter","link":"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/3-3-administration-considerations\/","title":{"raw":"3.5 Administration Considerations","rendered":"3.5 Administration Considerations"},"content":{"raw":"The administration of antimicrobial drug therapy involves special considerations to ensure that the therapeutic drug effect is achieved while maintaining client safety and minimizing complications.\r\n\r\nLet's consider some of the variables that may impact antimicrobial administration:\r\n\r\n[caption id=\"attachment_87\" align=\"alignright\" width=\"414\"]<img class=\"wp-image-86\" title=\"&quot;Concentration_vs_number_of_half-life_periodes.png&quot; by OPPSD is licensed under CC BY-SA 3.0\" src=\"https:\/\/opentextbc.ca\/accessibilitytoolkit\/wp-content\/uploads\/sites\/397\/2019\/09\/Medication-half-live-300x296.png\" alt=\"Graph showing Medication concentration over time demonstrates half-life.\" width=\"414\" height=\"408\" \/> Figure 3.5a Medication concentration over time demonstrates half-life[\/caption]\r\n<h1>Half-Life<\/h1>\r\n<span style=\"text-align: initial; font-size: 1em;\">Many antimicrobial medications are administered to ensure that a certain therapeutic level of medication remains in the bloodstream, and may require interval or repeated dosing throughout the day. For example, the <\/span><strong style=\"text-align: initial; font-size: 1em;\">[pb_glossary id=\"596\"]half-life[\/pb_glossary]<\/strong><span style=\"text-align: initial; font-size: 1em;\">, or rate at which 50% of a drug is eliminated from the plasma, can vary significantly between drugs. Some drugs have a short half-life of only 1 hour and must be given multiple times a day, but other drugs have half-lives exceeding 12 hours and can be given as a single dose every 24 hours. Although a longer half-life can be considered an advantage for an antibacterial when it comes to convenient dosing intervals, the longer half-life can also be a concern for a drug with serious side effects. Medications that have longer half-life and more concerning side effects will exert these side effects over a longer period of time.<\/span>\r\n\r\nSee Figure 3.5a[footnote]\"<a href=\"https:\/\/en.wikipedia.org\/wiki\/File:Concentration_vs_number_of_half-life_periodes.png\" rel=\"noopener noreferrer\">Concentration_vs_number_of_half-life_periodes.png<\/a>\" by OPPSD is licensed under <a class=\"internal\" href=\"https:\/\/creativecommons.org\/licenses\/by-sa\/3.0\/\" rel=\"noopener noreferrer\">CC BY-SA 3.0<\/a>[\/footnote] for an illustration of half-lives and the time it takes for a medication to be eliminated from the bloodstream.\r\n<h1>Lifespan Considerations<\/h1>\r\nA majority of medications are calculated specifically based on the client's size, weight, and renal function. Client age and size are especially vital in pediatric clients. A child's stage of development and the size of their internal organs will greatly impact how the body absorbs, digests, metabolizes, and eliminates medications.\r\n<h1>Liver &amp; Renal Function<\/h1>\r\nAdditionally, there are many antimicrobial medications that will require tailored dosing based on individual client response and the potential impact of the medication on the client's liver and renal function. For more information about the effects of liver and renal function on medications, refer to Chapter 1 regarding metabolism and excretion.\u00a0 Oftentimes, pharmacists and providers will collect [pb_glossary id=\"567\"]peak [\/pb_glossary] and [pb_glossary id=\"807\"]trough [\/pb_glossary] drug blood levels to determine how an individual client's body is responding to an antimicrobial. Follow-up interval dosing is then prescribed based on these blood levels. This is especially important for older adults or those with known liver\/renal impairment. Individuals with diminished liver and renal function are more prone to drug toxicity because of the reduced ability of the body to metabolize or clear medications from the body. For more information about peak and trough levels, refer to Chapter 1 regarding medication safety.\r\n<h1>Dose Dependency\/Time Dependency<\/h1>\r\nThe goal of antimicrobial therapy is to select an optimal dosage that will result in clinical cure, while reducing complications or significant side effects. Many medications may be <strong>[pb_glossary id=\"597\"]dose-dependent[\/pb_glossary]<\/strong>. This means that there is a more significant killing of the bacterial with increasing levels of the antibiotic.\u00a0 For example, fluroquinolones are dose-dependent medications with the treatment goal to optimize the amount of the drug. Other medications are <strong>[pb_glossary id=\"598\"]time-dependent[\/pb_glossary]<\/strong>. Time-dependent medications have optimal bacterial killing effect at lower doses over a longer period of time. Time-dependent antimicrobials exert the greatest effect by binding to the microorganism for an extensive length of time.\u00a0 Penicillin is an example of a time-dependent medication where the goal is to optimize the duration of exposure.\r\n<h1>Route<\/h1>\r\nIt is also important to consider the route of drug administration within the client's body. Many of us may have been prescribed oral antibiotics and have simply filled our prescription and completed the drug regimen within the comfort of our own homes. However, there are many types of infections or disease processes that do not respond well to the use of oral antimicrobial therapy. For these diseases, clients may require intravenous or intramuscular injections. Clients requiring intravenous or intramuscular injections may need to be hospitalized, have home health nursing arranged, or travel to the hospital\/clinic for their therapy. Concerns with treatment compliance exists with all routes of administration.\u00a0 For more information about considerations regarding routes of administration, refer to Chapter 1 on absorption. See Figure 3.7[footnote]\"<a href=\"https:\/\/images.nigms.nih.gov\/Pages\/DetailPage.aspx?imageID2=2528\" rel=\"noopener noreferrer\">A drug's life in the body (with labels)<\/a>\" by <a href=\"https:\/\/images.nigms.nih.gov\/Pages\/Home.aspx\" rel=\"noopener noreferrer\">National Institute of General Medical Sciences Image and Video Gallery<\/a> is licensed under <a class=\"internal\" href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/\" rel=\"noopener noreferrer\">CC NC-SA 3.0<\/a>[\/footnote] for an illustration of three common routes of medication within the body.\r\n\r\n[caption id=\"attachment_87\" align=\"aligncenter\" width=\"682\"]<img class=\"wp-image-87\" title=\"&quot;A drug's life in the body (with labels)&quot; by National Institute of General Medical Sciences Image and Video Gallery is licensed under CC NC-SA 3.0\" src=\"https:\/\/opentextbc.ca\/accessibilitytoolkit\/wp-content\/uploads\/sites\/397\/2022\/05\/Routes-of-medication-administration-915x1024.png\" alt=\"Illustration of human body, from waist up, showing routes of medication administration \" width=\"682\" height=\"763\" \/> Figure 3.5b Common routes of medication administration include oral, inhalation, and IV[\/caption]\r\n<h1>Drug Interactions<\/h1>\r\nFor the optimum treatment of select infections, two antibacterial drugs may be administered together. Concurrent drug administration produces a <strong>[pb_glossary id=\"599\"]synergistic interaction [\/pb_glossary] <\/strong>that is better than the efficacy of either drug alone. In this case, TWO is truly better than ONE! A classic example of synergistic drug combinations is trimethoprim and sulfamethoxazole (Bactrim). Individually, these two drugs provide only bacteriostatic inhibition of bacterial growth, but combined, the drugs are bactericidal.\r\n\r\nAlthough synergistic drug interactions provide a benefit to the client, <strong>[pb_glossary id=\"600\"]antagonistic interactions [\/pb_glossary]<\/strong> produce harmful effects. Antagonism can occur between two antimicrobials or between antimicrobials and non-antimicrobials being used to treat other conditions. The effects vary depending on the drugs involved, but antagonistic interactions cause diminished drug activity, decreased therapeutic levels due to elevated metabolism and elimination, or increased potential for toxicity due to decreased metabolism and elimination.\r\n\r\nLet's consider an example of these antagonistic interactions.\r\n\r\nMany antibacterials are absorbed most effectively from the acidic environment within the stomach. However, if a client takes antacids, the antacids increase the pH of the stomach and negatively impact the absorption of the antibacterial, thus decreasing their effectiveness in treating an infection.\r\n<div class=\"textbox\">\r\n<h3 class=\"star\">\u00a0Interactive Activity<\/h3>\r\n[h5p id=\"7\"]\r\n\r\n<\/div>\r\n<h3>Attributions<\/h3>\r\n<ul>\r\n \t<li>This chapter includes content adapted from <a href=\"https:\/\/openstax.org\/details\/books\/microbiology\"><em>Microbiology<\/em><\/a> by Nina Parker, Mark Schneegurt, Anh-Hue Thi Tu, Philip Lister, Brian M. Forster (\u00a9 2022 OpenStax), which is licened under a <a class=\"internal\" href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\">CC BY 4.0 licence<\/a>.<\/li>\r\n<\/ul>","rendered":"<p>The administration of antimicrobial drug therapy involves special considerations to ensure that the therapeutic drug effect is achieved while maintaining client safety and minimizing complications.<\/p>\n<p>Let&#8217;s consider some of the variables that may impact antimicrobial administration:<\/p>\n<figure id=\"attachment_87\" aria-describedby=\"caption-attachment-87\" style=\"width: 414px\" class=\"wp-caption alignright\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-86\" title=\"&quot;Concentration_vs_number_of_half-life_periodes.png&quot; by OPPSD is licensed under CC BY-SA 3.0\" src=\"https:\/\/opentextbc.ca\/accessibilitytoolkit\/wp-content\/uploads\/sites\/397\/2019\/09\/Medication-half-live-300x296.png\" alt=\"Graph showing Medication concentration over time demonstrates half-life.\" width=\"414\" height=\"408\" srcset=\"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2019\/09\/Medication-half-live-300x296.png 300w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2019\/09\/Medication-half-live-65x64.png 65w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2019\/09\/Medication-half-live-225x222.png 225w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2019\/09\/Medication-half-live-350x345.png 350w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2019\/09\/Medication-half-live.png 491w\" sizes=\"auto, (max-width: 414px) 100vw, 414px\" \/><figcaption id=\"caption-attachment-87\" class=\"wp-caption-text\">Figure 3.5a Medication concentration over time demonstrates half-life<\/figcaption><\/figure>\n<h1>Half-Life<\/h1>\n<p><span style=\"text-align: initial; font-size: 1em;\">Many antimicrobial medications are administered to ensure that a certain therapeutic level of medication remains in the bloodstream, and may require interval or repeated dosing throughout the day. For example, the <\/span><strong style=\"text-align: initial; font-size: 1em;\"><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_88_596\">half-life<\/a><\/strong><span style=\"text-align: initial; font-size: 1em;\">, or rate at which 50% of a drug is eliminated from the plasma, can vary significantly between drugs. Some drugs have a short half-life of only 1 hour and must be given multiple times a day, but other drugs have half-lives exceeding 12 hours and can be given as a single dose every 24 hours. Although a longer half-life can be considered an advantage for an antibacterial when it comes to convenient dosing intervals, the longer half-life can also be a concern for a drug with serious side effects. Medications that have longer half-life and more concerning side effects will exert these side effects over a longer period of time.<\/span><\/p>\n<p>See Figure 3.5a<a class=\"footnote\" title=\"&quot;Concentration_vs_number_of_half-life_periodes.png&quot; by OPPSD is licensed under CC BY-SA 3.0\" id=\"return-footnote-88-1\" href=\"#footnote-88-1\" aria-label=\"Footnote 1\"><sup class=\"footnote\">[1]<\/sup><\/a> for an illustration of half-lives and the time it takes for a medication to be eliminated from the bloodstream.<\/p>\n<h1>Lifespan Considerations<\/h1>\n<p>A majority of medications are calculated specifically based on the client&#8217;s size, weight, and renal function. Client age and size are especially vital in pediatric clients. A child&#8217;s stage of development and the size of their internal organs will greatly impact how the body absorbs, digests, metabolizes, and eliminates medications.<\/p>\n<h1>Liver &amp; Renal Function<\/h1>\n<p>Additionally, there are many antimicrobial medications that will require tailored dosing based on individual client response and the potential impact of the medication on the client&#8217;s liver and renal function. For more information about the effects of liver and renal function on medications, refer to Chapter 1 regarding metabolism and excretion.\u00a0 Oftentimes, pharmacists and providers will collect <a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_88_567\">peak <\/a> and <a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_88_807\">trough <\/a> drug blood levels to determine how an individual client&#8217;s body is responding to an antimicrobial. Follow-up interval dosing is then prescribed based on these blood levels. This is especially important for older adults or those with known liver\/renal impairment. Individuals with diminished liver and renal function are more prone to drug toxicity because of the reduced ability of the body to metabolize or clear medications from the body. For more information about peak and trough levels, refer to Chapter 1 regarding medication safety.<\/p>\n<h1>Dose Dependency\/Time Dependency<\/h1>\n<p>The goal of antimicrobial therapy is to select an optimal dosage that will result in clinical cure, while reducing complications or significant side effects. Many medications may be <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_88_597\">dose-dependent<\/a><\/strong>. This means that there is a more significant killing of the bacterial with increasing levels of the antibiotic.\u00a0 For example, fluroquinolones are dose-dependent medications with the treatment goal to optimize the amount of the drug. Other medications are <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_88_598\">time-dependent<\/a><\/strong>. Time-dependent medications have optimal bacterial killing effect at lower doses over a longer period of time. Time-dependent antimicrobials exert the greatest effect by binding to the microorganism for an extensive length of time.\u00a0 Penicillin is an example of a time-dependent medication where the goal is to optimize the duration of exposure.<\/p>\n<h1>Route<\/h1>\n<p>It is also important to consider the route of drug administration within the client&#8217;s body. Many of us may have been prescribed oral antibiotics and have simply filled our prescription and completed the drug regimen within the comfort of our own homes. However, there are many types of infections or disease processes that do not respond well to the use of oral antimicrobial therapy. For these diseases, clients may require intravenous or intramuscular injections. Clients requiring intravenous or intramuscular injections may need to be hospitalized, have home health nursing arranged, or travel to the hospital\/clinic for their therapy. Concerns with treatment compliance exists with all routes of administration.\u00a0 For more information about considerations regarding routes of administration, refer to Chapter 1 on absorption. See Figure 3.7<a class=\"footnote\" title=\"&quot;A drug's life in the body (with labels)&quot; by National Institute of General Medical Sciences Image and Video Gallery is licensed under CC NC-SA 3.0\" id=\"return-footnote-88-2\" href=\"#footnote-88-2\" aria-label=\"Footnote 2\"><sup class=\"footnote\">[2]<\/sup><\/a> for an illustration of three common routes of medication within the body.<\/p>\n<figure id=\"attachment_87\" aria-describedby=\"caption-attachment-87\" style=\"width: 682px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-87\" title=\"&quot;A drug's life in the body (with labels)&quot; by National Institute of General Medical Sciences Image and Video Gallery is licensed under CC NC-SA 3.0\" src=\"https:\/\/opentextbc.ca\/accessibilitytoolkit\/wp-content\/uploads\/sites\/397\/2022\/05\/Routes-of-medication-administration-915x1024.png\" alt=\"Illustration of human body, from waist up, showing routes of medication administration\" width=\"682\" height=\"763\" srcset=\"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2022\/05\/Routes-of-medication-administration-915x1024.png 915w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2022\/05\/Routes-of-medication-administration-268x300.png 268w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2022\/05\/Routes-of-medication-administration-768x859.png 768w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2022\/05\/Routes-of-medication-administration-1373x1536.png 1373w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2022\/05\/Routes-of-medication-administration-65x73.png 65w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2022\/05\/Routes-of-medication-administration-225x252.png 225w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2022\/05\/Routes-of-medication-administration-350x392.png 350w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2022\/05\/Routes-of-medication-administration.png 1430w\" sizes=\"auto, (max-width: 682px) 100vw, 682px\" \/><figcaption id=\"caption-attachment-87\" class=\"wp-caption-text\">Figure 3.5b Common routes of medication administration include oral, inhalation, and IV<\/figcaption><\/figure>\n<h1>Drug Interactions<\/h1>\n<p>For the optimum treatment of select infections, two antibacterial drugs may be administered together. Concurrent drug administration produces a <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_88_599\">synergistic interaction <\/a> <\/strong>that is better than the efficacy of either drug alone. In this case, TWO is truly better than ONE! A classic example of synergistic drug combinations is trimethoprim and sulfamethoxazole (Bactrim). Individually, these two drugs provide only bacteriostatic inhibition of bacterial growth, but combined, the drugs are bactericidal.<\/p>\n<p>Although synergistic drug interactions provide a benefit to the client, <strong><a class=\"glossary-term\" aria-haspopup=\"dialog\" aria-describedby=\"definition\" href=\"#term_88_600\">antagonistic interactions <\/a><\/strong> produce harmful effects. Antagonism can occur between two antimicrobials or between antimicrobials and non-antimicrobials being used to treat other conditions. The effects vary depending on the drugs involved, but antagonistic interactions cause diminished drug activity, decreased therapeutic levels due to elevated metabolism and elimination, or increased potential for toxicity due to decreased metabolism and elimination.<\/p>\n<p>Let&#8217;s consider an example of these antagonistic interactions.<\/p>\n<p>Many antibacterials are absorbed most effectively from the acidic environment within the stomach. However, if a client takes antacids, the antacids increase the pH of the stomach and negatively impact the absorption of the antibacterial, thus decreasing their effectiveness in treating an infection.<\/p>\n<div class=\"textbox\">\n<h3 class=\"star\">\u00a0Interactive Activity<\/h3>\n<div id=\"h5p-7\">\n<div class=\"h5p-iframe-wrapper\"><iframe id=\"h5p-iframe-7\" class=\"h5p-iframe\" data-content-id=\"7\" style=\"height:1px\" src=\"about:blank\" frameBorder=\"0\" scrolling=\"no\" title=\"Module 4: Antimicrobial Basics Knowledge Check\"><\/iframe><\/div>\n<\/div>\n<\/div>\n<h3>Attributions<\/h3>\n<ul>\n<li>This chapter includes content adapted from <a href=\"https:\/\/openstax.org\/details\/books\/microbiology\"><em>Microbiology<\/em><\/a> by Nina Parker, Mark Schneegurt, Anh-Hue Thi Tu, Philip Lister, Brian M. Forster (\u00a9 2022 OpenStax), which is licened under a <a class=\"internal\" href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\">CC BY 4.0 licence<\/a>.<\/li>\n<\/ul>\n<hr class=\"before-footnotes clear\" \/><div class=\"footnotes\"><ol><li id=\"footnote-88-1\">\"<a href=\"https:\/\/en.wikipedia.org\/wiki\/File:Concentration_vs_number_of_half-life_periodes.png\" rel=\"noopener noreferrer\">Concentration_vs_number_of_half-life_periodes.png<\/a>\" by OPPSD is licensed under <a class=\"internal\" href=\"https:\/\/creativecommons.org\/licenses\/by-sa\/3.0\/\" rel=\"noopener noreferrer\">CC BY-SA 3.0<\/a> <a href=\"#return-footnote-88-1\" class=\"return-footnote\" aria-label=\"Return to footnote 1\">&crarr;<\/a><\/li><li id=\"footnote-88-2\">\"<a href=\"https:\/\/images.nigms.nih.gov\/Pages\/DetailPage.aspx?imageID2=2528\" rel=\"noopener noreferrer\">A drug's life in the body (with labels)<\/a>\" by <a href=\"https:\/\/images.nigms.nih.gov\/Pages\/Home.aspx\" rel=\"noopener noreferrer\">National Institute of General Medical Sciences Image and Video Gallery<\/a> is licensed under <a class=\"internal\" href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/\" rel=\"noopener noreferrer\">CC NC-SA 3.0<\/a> <a href=\"#return-footnote-88-2\" class=\"return-footnote\" aria-label=\"Return to footnote 2\">&crarr;<\/a><\/li><\/ol><\/div><div class=\"glossary\"><span class=\"screen-reader-text\" id=\"definition\">definition<\/span><template id=\"term_88_596\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_88_596\"><div tabindex=\"-1\"><p>The rate at which 50% of a drug is eliminated from the bloodstream.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_88_567\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_88_567\"><div tabindex=\"-1\"><p>When the maximum concentration of drug is in the body.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_88_807\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_88_807\"><div tabindex=\"-1\"><p>The trough level of medication indicates the lowest concentration of that medication in a person's body. Troughs of medication concentration occur after the drug has been broken down and metabolized by the body.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_88_597\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_88_597\"><div tabindex=\"-1\"><p>A more significant response occurs in the body when the medication is administered in large doses to provide a large amount of medication to the site of infection for a short period of time.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_88_598\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_88_598\"><div tabindex=\"-1\"><p>Time dependency occurs when greater therapeutic effects are seen with lower blood levels over a longer period of time.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_88_599\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_88_599\"><div tabindex=\"-1\"><p>Concurrent drug administration producing a synergistic interaction that is better than the efficacy of either drug alone.  An example of synergistic drug combinations is trimethoprim and sulfamethoxazole (Bactrim).<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><template id=\"term_88_600\"><div class=\"glossary__definition\" role=\"dialog\" data-id=\"term_88_600\"><div tabindex=\"-1\"><p>Concurrent administration of two drugs causes harmful effects such as a decrease of drug activity, decreased therapeutic levels due to increased metabolism and elimination, or increased potential for toxicity due to decreased metabolism and elimination.  An example of an antagonistic interaction is taking antacids with antibiotics, causing decreased absorption of the antibiotic.<\/p>\n<\/div><button><span aria-hidden=\"true\">&times;<\/span><span class=\"screen-reader-text\">Close definition<\/span><\/button><\/div><\/template><\/div>","protected":false},"author":90,"menu_order":5,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":[],"pb_section_license":""},"chapter-type":[50],"contributor":[],"license":[],"class_list":["post-88","chapter","type-chapter","status-publish","hentry","chapter-type-numberless"],"part":70,"_links":{"self":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/88","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/users\/90"}],"version-history":[{"count":9,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/88\/revisions"}],"predecessor-version":[{"id":1647,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/88\/revisions\/1647"}],"part":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/70"}],"metadata":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/88\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/media?parent=88"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=88"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/contributor?post=88"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/license?post=88"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}